Back to Startups

GlycoEra AG

Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
Bioscience & Disease Healthcare Systems
Bioscience & Disease Healthcare Systems Show less
@GlycoEra Website LinkedIn Zurich
About GlycoEra AG

GlycoEra AG is a biotechnology startup focused on the development of innovative glycoengineering technologies to enhance the production of glycoproteins for therapeutic applications. The company aims to revolutionize the biopharmaceutical industry by improving the efficiency and efficacy of drug development through advanced glycosylation techniques.

Business Information
Target Customers
pharmaceutical companies biotech firms research institutions
Industry Categories
Bioscience & Disease Healthcare Systems
Business Model
Revenue Model B2B services
Pricing Strategy Project-based pricing
Sales Channels direct sales, partnerships
Funding Timeline

No funding rounds recorded for this startup.

Founders

No founder information available.

Investors

No investor information available.

Recent Mentions
mattliptak
Matthew Liptak @mattliptak
May 27, 2025

Novo Holdings leads $130M round in Newton's GlycoEra AG - Boston Business Journal https://t.co/rly9MdVDzB via @BosBizJournal

View on Twitter
Similar Startups
CureGene Pharma
87% match

CureGene focuses on therapeutic areas including cardiovascular and metabolic diseases, developing in...
Zucara Therapeutics Inc.
86% match

A diabetes life sciences company focused on developing innovative therapies to improve the lives of ...
AusperBio
85% match

A clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies.
Epogee
85% match

Epogee is a food tech company focused on developing innovative ingredient profiles that enhance the ...